Clinical trial
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis…
NCT00004986 · Romark Laboratories L.C., Industry · Terminated
Key facts
| NCT number | NCT00004986 |
|---|---|
| Title | Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients |
| Official title | Open Label, Multi-Center Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in Subjects With AIDS in the United States |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cryptosporidiosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| Enrollment | 30 |
| Start date | Feb 1, 2000 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: